Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › GSNO reductase inhibitor as an adjunct therapy in cerebral thrombosis and/or thromboembolic stroke

GSNO reductase inhibitor as an adjunct therapy in cerebral thrombosis and/or thromboembolic stroke

US Patent 11260051 · Granted Mar 1, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

GSNO reductase inhibitor as an adjunct therapy with remote ischemic conditioning2022
GSNO reductase inhibitor as an adjunct therapy with remote ischemic conditioning2022
GSNO reductase inhibitor as an adjunct therapy with remote ischemic conditioning2022
GSNO reductase inhibitor as an adjunct therapy with remote ischemic conditioning2021
GSNO reductase inhibitor as an adjunct therapy with remote ischemic conditioning2021
GSNO reductase inhibitor as an adjunct therapy with remote ischemic conditioning2021
Simplified PCR method for the detection of common neuploides in human reimplanta2021